Pefloxacin Mesylate Market

1 Study Coverage
    1.1 Pefloxacin Mesylate Product Introduction
    1.2 Market by Type
        1.2.1 Global Pefloxacin Mesylate Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Tablet
        1.2.3 Capsule
        1.2.4 Injection
    1.3 Market by Application
        1.3.1 Global Pefloxacin Mesylate Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Pefloxacin Mesylate Sales Estimates and Forecasts 2017-2028
    2.2 Global Pefloxacin Mesylate Revenue Estimates and Forecasts 2017-2028
    2.3 Global Pefloxacin Mesylate Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Pefloxacin Mesylate Sales by Region
        2.4.1 Global Pefloxacin Mesylate Sales by Region (2017-2022)
        2.4.2 Global Sales Pefloxacin Mesylate by Region (2023-2028)
    2.5 Global Pefloxacin Mesylate Revenue by Region
        2.5.1 Global Pefloxacin Mesylate Revenue by Region (2017-2022)
        2.5.2 Global Pefloxacin Mesylate Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Pefloxacin Mesylate Sales by Manufacturers
        3.1.1 Global Top Pefloxacin Mesylate Manufacturers by Sales (2017-2022)
        3.1.2 Global Pefloxacin Mesylate Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pefloxacin Mesylate in 2021
    3.2 Global Pefloxacin Mesylate Revenue by Manufacturers
        3.2.1 Global Pefloxacin Mesylate Revenue by Manufacturers (2017-2022)
        3.2.2 Global Pefloxacin Mesylate Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Pefloxacin Mesylate Revenue in 2021
    3.3 Global Pefloxacin Mesylate Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Pefloxacin Mesylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Pefloxacin Mesylate Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Pefloxacin Mesylate Sales by Type
        4.1.1 Global Pefloxacin Mesylate Historical Sales by Type (2017-2022)
        4.1.2 Global Pefloxacin Mesylate Forecasted Sales by Type (2023-2028)
        4.1.3 Global Pefloxacin Mesylate Sales Market Share by Type (2017-2028)
    4.2 Global Pefloxacin Mesylate Revenue by Type
        4.2.1 Global Pefloxacin Mesylate Historical Revenue by Type (2017-2022)
        4.2.2 Global Pefloxacin Mesylate Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Pefloxacin Mesylate Revenue Market Share by Type (2017-2028)
    4.3 Global Pefloxacin Mesylate Price by Type
        4.3.1 Global Pefloxacin Mesylate Price by Type (2017-2022)
        4.3.2 Global Pefloxacin Mesylate Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Pefloxacin Mesylate Sales by Application
        5.1.1 Global Pefloxacin Mesylate Historical Sales by Application (2017-2022)
        5.1.2 Global Pefloxacin Mesylate Forecasted Sales by Application (2023-2028)
        5.1.3 Global Pefloxacin Mesylate Sales Market Share by Application (2017-2028)
    5.2 Global Pefloxacin Mesylate Revenue by Application
        5.2.1 Global Pefloxacin Mesylate Historical Revenue by Application (2017-2022)
        5.2.2 Global Pefloxacin Mesylate Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Pefloxacin Mesylate Revenue Market Share by Application (2017-2028)
    5.3 Global Pefloxacin Mesylate Price by Application
        5.3.1 Global Pefloxacin Mesylate Price by Application (2017-2022)
        5.3.2 Global Pefloxacin Mesylate Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Pefloxacin Mesylate Market Size by Type
        6.1.1 North America Pefloxacin Mesylate Sales by Type (2017-2028)
        6.1.2 North America Pefloxacin Mesylate Revenue by Type (2017-2028)
    6.2 North America Pefloxacin Mesylate Market Size by Application
        6.2.1 North America Pefloxacin Mesylate Sales by Application (2017-2028)
        6.2.2 North America Pefloxacin Mesylate Revenue by Application (2017-2028)
    6.3 North America Pefloxacin Mesylate Market Size by Country
        6.3.1 North America Pefloxacin Mesylate Sales by Country (2017-2028)
        6.3.2 North America Pefloxacin Mesylate Revenue by Country (2017-2028)
        6.3.3 United States
        6.3.4 Canada
7 Europe
    7.1 Europe Pefloxacin Mesylate Market Size by Type
        7.1.1 Europe Pefloxacin Mesylate Sales by Type (2017-2028)
        7.1.2 Europe Pefloxacin Mesylate Revenue by Type (2017-2028)
    7.2 Europe Pefloxacin Mesylate Market Size by Application
        7.2.1 Europe Pefloxacin Mesylate Sales by Application (2017-2028)
        7.2.2 Europe Pefloxacin Mesylate Revenue by Application (2017-2028)
    7.3 Europe Pefloxacin Mesylate Market Size by Country
        7.3.1 Europe Pefloxacin Mesylate Sales by Country (2017-2028)
        7.3.2 Europe Pefloxacin Mesylate Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Pefloxacin Mesylate Market Size by Type
        8.1.1 Asia Pacific Pefloxacin Mesylate Sales by Type (2017-2028)
        8.1.2 Asia Pacific Pefloxacin Mesylate Revenue by Type (2017-2028)
    8.2 Asia Pacific Pefloxacin Mesylate Market Size by Application
        8.2.1 Asia Pacific Pefloxacin Mesylate Sales by Application (2017-2028)
        8.2.2 Asia Pacific Pefloxacin Mesylate Revenue by Application (2017-2028)
    8.3 Asia Pacific Pefloxacin Mesylate Market Size by Region
        8.3.1 Asia Pacific Pefloxacin Mesylate Sales by Region (2017-2028)
        8.3.2 Asia Pacific Pefloxacin Mesylate Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Pefloxacin Mesylate Market Size by Type
        9.1.1 Latin America Pefloxacin Mesylate Sales by Type (2017-2028)
        9.1.2 Latin America Pefloxacin Mesylate Revenue by Type (2017-2028)
    9.2 Latin America Pefloxacin Mesylate Market Size by Application
        9.2.1 Latin America Pefloxacin Mesylate Sales by Application (2017-2028)
        9.2.2 Latin America Pefloxacin Mesylate Revenue by Application (2017-2028)
    9.3 Latin America Pefloxacin Mesylate Market Size by Country
        9.3.1 Latin America Pefloxacin Mesylate Sales by Country (2017-2028)
        9.3.2 Latin America Pefloxacin Mesylate Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
        9.3.6 Colombia
10 Middle East and Africa
    10.1 Middle East and Africa Pefloxacin Mesylate Market Size by Type
        10.1.1 Middle East and Africa Pefloxacin Mesylate Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Pefloxacin Mesylate Revenue by Type (2017-2028)
    10.2 Middle East and Africa Pefloxacin Mesylate Market Size by Application
        10.2.1 Middle East and Africa Pefloxacin Mesylate Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Pefloxacin Mesylate Revenue by Application (2017-2028)
    10.3 Middle East and Africa Pefloxacin Mesylate Market Size by Country
        10.3.1 Middle East and Africa Pefloxacin Mesylate Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Pefloxacin Mesylate Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 AdvaCare Pharma
        11.1.1 AdvaCare Pharma Corporation Information
        11.1.2 AdvaCare Pharma Overview
        11.1.3 AdvaCare Pharma Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 AdvaCare Pharma Pefloxacin Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 AdvaCare Pharma Recent Developments
    11.2 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd.
        11.2.1 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Corporation Information
        11.2.2 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Overview
        11.2.3 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Pefloxacin Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Recent Developments
    11.3 Ruiyang Pharmaceutical Co., Ltd.
        11.3.1 Ruiyang Pharmaceutical Co., Ltd. Corporation Information
        11.3.2 Ruiyang Pharmaceutical Co., Ltd. Overview
        11.3.3 Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Ruiyang Pharmaceutical Co., Ltd. Recent Developments
    11.4 Yichang Renfu Pharmaceutical Co., Ltd.
        11.4.1 Yichang Renfu Pharmaceutical Co., Ltd. Corporation Information
        11.4.2 Yichang Renfu Pharmaceutical Co., Ltd. Overview
        11.4.3 Yichang Renfu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Yichang Renfu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Yichang Renfu Pharmaceutical Co., Ltd. Recent Developments
    11.5 Shandong Lukang Pharmaceutical Group Saite Co., Ltd.
        11.5.1 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Corporation Information
        11.5.2 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Overview
        11.5.3 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Pefloxacin Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Recent Developments
    11.6 CommScope Pharmaceutical Co., Ltd.
        11.6.1 CommScope Pharmaceutical Co., Ltd. Corporation Information
        11.6.2 CommScope Pharmaceutical Co., Ltd. Overview
        11.6.3 CommScope Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 CommScope Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 CommScope Pharmaceutical Co., Ltd. Recent Developments
    11.7 Beijing Shuanglu Pharmaceutical Co., Ltd.
        11.7.1 Beijing Shuanglu Pharmaceutical Co., Ltd. Corporation Information
        11.7.2 Beijing Shuanglu Pharmaceutical Co., Ltd. Overview
        11.7.3 Beijing Shuanglu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Beijing Shuanglu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Developments
    11.8 Beijing Sihuan Pharmaceutical Co., Ltd.
        11.8.1 Beijing Sihuan Pharmaceutical Co., Ltd. Corporation Information
        11.8.2 Beijing Sihuan Pharmaceutical Co., Ltd. Overview
        11.8.3 Beijing Sihuan Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Beijing Sihuan Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Beijing Sihuan Pharmaceutical Co., Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Pefloxacin Mesylate Industry Chain Analysis
    12.2 Pefloxacin Mesylate Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Pefloxacin Mesylate Production Mode & Process
    12.4 Pefloxacin Mesylate Sales and Marketing
        12.4.1 Pefloxacin Mesylate Sales Channels
        12.4.2 Pefloxacin Mesylate Distributors
    12.5 Pefloxacin Mesylate Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Pefloxacin Mesylate Industry Trends
    13.2 Pefloxacin Mesylate Market Drivers
    13.3 Pefloxacin Mesylate Market Challenges
    13.4 Pefloxacin Mesylate Market Restraints
14 Key Findings in The Global Pefloxacin Mesylate Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Pefloxacin Mesylate Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Tablet
    Table 3. Major Manufacturers of Capsule
    Table 4. Major Manufacturers of Injection
    Table 5. Global Pefloxacin Mesylate Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Pefloxacin Mesylate Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Pefloxacin Mesylate Sales by Region (2017-2022) & (K Units)
    Table 8. Global Pefloxacin Mesylate Sales Market Share by Region (2017-2022)
    Table 9. Global Pefloxacin Mesylate Sales by Region (2023-2028) & (K Units)
    Table 10. Global Pefloxacin Mesylate Sales Market Share by Region (2023-2028)
    Table 11. Global Pefloxacin Mesylate Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Pefloxacin Mesylate Revenue Market Share by Region (2017-2022)
    Table 13. Global Pefloxacin Mesylate Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Pefloxacin Mesylate Revenue Market Share by Region (2023-2028)
    Table 15. Global Pefloxacin Mesylate Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Pefloxacin Mesylate Sales Share by Manufacturers (2017-2022)
    Table 17. Global Pefloxacin Mesylate Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Pefloxacin Mesylate Revenue Share by Manufacturers (2017-2022)
    Table 19. Pefloxacin Mesylate Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 20. Global Pefloxacin Mesylate Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Pefloxacin Mesylate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pefloxacin Mesylate as of 2021)
    Table 22. Pefloxacin Mesylate Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Pefloxacin Mesylate Product Offered
    Table 24. Date of Manufacturers Enter into Pefloxacin Mesylate Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Pefloxacin Mesylate Sales by Type (2017-2022) & (K Units)
    Table 27. Global Pefloxacin Mesylate Sales by Type (2023-2028) & (K Units)
    Table 28. Global Pefloxacin Mesylate Sales Share by Type (2017-2022)
    Table 29. Global Pefloxacin Mesylate Sales Share by Type (2023-2028)
    Table 30. Global Pefloxacin Mesylate Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Pefloxacin Mesylate Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Pefloxacin Mesylate Revenue Share by Type (2017-2022)
    Table 33. Global Pefloxacin Mesylate Revenue Share by Type (2023-2028)
    Table 34. Pefloxacin Mesylate Price by Type (2017-2022) & (US$/Unit)
    Table 35. Global Pefloxacin Mesylate Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 36. Global Pefloxacin Mesylate Sales by Application (2017-2022) & (K Units)
    Table 37. Global Pefloxacin Mesylate Sales by Application (2023-2028) & (K Units)
    Table 38. Global Pefloxacin Mesylate Sales Share by Application (2017-2022)
    Table 39. Global Pefloxacin Mesylate Sales Share by Application (2023-2028)
    Table 40. Global Pefloxacin Mesylate Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Pefloxacin Mesylate Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Pefloxacin Mesylate Revenue Share by Application (2017-2022)
    Table 43. Global Pefloxacin Mesylate Revenue Share by Application (2023-2028)
    Table 44. Pefloxacin Mesylate Price by Application (2017-2022) & (US$/Unit)
    Table 45. Global Pefloxacin Mesylate Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 46. North America Pefloxacin Mesylate Sales by Type (2017-2022) & (K Units)
    Table 47. North America Pefloxacin Mesylate Sales by Type (2023-2028) & (K Units)
    Table 48. North America Pefloxacin Mesylate Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Pefloxacin Mesylate Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Pefloxacin Mesylate Sales by Application (2017-2022) & (K Units)
    Table 51. North America Pefloxacin Mesylate Sales by Application (2023-2028) & (K Units)
    Table 52. North America Pefloxacin Mesylate Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Pefloxacin Mesylate Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Pefloxacin Mesylate Sales by Country (2017-2022) & (K Units)
    Table 55. North America Pefloxacin Mesylate Sales by Country (2023-2028) & (K Units)
    Table 56. North America Pefloxacin Mesylate Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Pefloxacin Mesylate Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Pefloxacin Mesylate Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Pefloxacin Mesylate Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Pefloxacin Mesylate Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Pefloxacin Mesylate Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Pefloxacin Mesylate Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Pefloxacin Mesylate Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Pefloxacin Mesylate Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Pefloxacin Mesylate Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Pefloxacin Mesylate Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Pefloxacin Mesylate Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Pefloxacin Mesylate Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Pefloxacin Mesylate Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Pefloxacin Mesylate Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Pefloxacin Mesylate Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Pefloxacin Mesylate Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Pefloxacin Mesylate Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Pefloxacin Mesylate Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Pefloxacin Mesylate Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Pefloxacin Mesylate Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Pefloxacin Mesylate Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Pefloxacin Mesylate Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Pefloxacin Mesylate Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Pefloxacin Mesylate Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Pefloxacin Mesylate Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Pefloxacin Mesylate Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Pefloxacin Mesylate Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Pefloxacin Mesylate Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Pefloxacin Mesylate Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Pefloxacin Mesylate Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Pefloxacin Mesylate Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Pefloxacin Mesylate Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Pefloxacin Mesylate Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Pefloxacin Mesylate Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Pefloxacin Mesylate Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Pefloxacin Mesylate Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Pefloxacin Mesylate Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Pefloxacin Mesylate Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Pefloxacin Mesylate Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Pefloxacin Mesylate Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Pefloxacin Mesylate Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Pefloxacin Mesylate Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Pefloxacin Mesylate Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Pefloxacin Mesylate Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Pefloxacin Mesylate Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Pefloxacin Mesylate Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Pefloxacin Mesylate Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Pefloxacin Mesylate Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Pefloxacin Mesylate Revenue by Country (2023-2028) & (US$ Million)
    Table 106. AdvaCare Pharma Corporation Information
    Table 107. AdvaCare Pharma Description and Major Businesses
    Table 108. AdvaCare Pharma Pefloxacin Mesylate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 109. AdvaCare Pharma Pefloxacin Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. AdvaCare Pharma Recent Developments
    Table 111. China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Corporation Information
    Table 112. China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Description and Major Businesses
    Table 113. China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 114. China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Pefloxacin Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Recent Developments
    Table 116. Ruiyang Pharmaceutical Co., Ltd. Corporation Information
    Table 117. Ruiyang Pharmaceutical Co., Ltd. Description and Major Businesses
    Table 118. Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 119. Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Ruiyang Pharmaceutical Co., Ltd. Recent Developments
    Table 121. Yichang Renfu Pharmaceutical Co., Ltd. Corporation Information
    Table 122. Yichang Renfu Pharmaceutical Co., Ltd. Description and Major Businesses
    Table 123. Yichang Renfu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 124. Yichang Renfu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Yichang Renfu Pharmaceutical Co., Ltd. Recent Developments
    Table 126. Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Corporation Information
    Table 127. Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Description and Major Businesses
    Table 128. Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 129. Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Pefloxacin Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Recent Developments
    Table 131. CommScope Pharmaceutical Co., Ltd. Corporation Information
    Table 132. CommScope Pharmaceutical Co., Ltd. Description and Major Businesses
    Table 133. CommScope Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 134. CommScope Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. CommScope Pharmaceutical Co., Ltd. Recent Developments
    Table 136. Beijing Shuanglu Pharmaceutical Co., Ltd. Corporation Information
    Table 137. Beijing Shuanglu Pharmaceutical Co., Ltd. Description and Major Businesses
    Table 138. Beijing Shuanglu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 139. Beijing Shuanglu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Developments
    Table 141. Beijing Sihuan Pharmaceutical Co., Ltd. Corporation Information
    Table 142. Beijing Sihuan Pharmaceutical Co., Ltd. Description and Major Businesses
    Table 143. Beijing Sihuan Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 144. Beijing Sihuan Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Beijing Sihuan Pharmaceutical Co., Ltd. Recent Developments
    Table 146. Key Raw Materials Lists
    Table 147. Raw Materials Key Suppliers Lists
    Table 148. Pefloxacin Mesylate Distributors List
    Table 149. Pefloxacin Mesylate Customers List
    Table 150. Pefloxacin Mesylate Market Trends
    Table 151. Pefloxacin Mesylate Market Drivers
    Table 152. Pefloxacin Mesylate Market Challenges
    Table 153. Pefloxacin Mesylate Market Restraints
    Table 154. Research Programs/Design for This Report
    Table 155. Key Data Information from Secondary Sources
    Table 156. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pefloxacin Mesylate Product Picture
    Figure 3. Global Pefloxacin Mesylate Market Share by Type in 2021 & 2028
    Figure 3. Tablet Product Picture
    Figure 4. Capsule Product Picture
    Figure 5. Injection Product Picture
    Figure 6. Global Pefloxacin Mesylate Market Share by Application in 2021 & 2028
    Figure 7. Hospital Pharmacy
    Figure 8. Retail Pharmacy
    Figure 9. Others
    Figure 10. Pefloxacin Mesylate Report Years Considered
    Figure 11. Global Pefloxacin Mesylate Sales 2017-2028 (K Units)
    Figure 12. Global Pefloxacin Mesylate Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Pefloxacin Mesylate Revenue 2017-2028 (US$ Million)
    Figure 14. Global Pefloxacin Mesylate Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Pefloxacin Mesylate Sales Market Share by Region (2017-2022)
    Figure 16. Global Pefloxacin Mesylate Sales Market Share by Region (2023-2028)
    Figure 17. North America Pefloxacin Mesylate Sales YoY (2017-2028) & (K Units)
    Figure 18. North America Pefloxacin Mesylate Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Pefloxacin Mesylate Sales YoY (2017-2028) & (K Units)
    Figure 20. Europe Pefloxacin Mesylate Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Pefloxacin Mesylate Sales YoY (2017-2028) & (K Units)
    Figure 22. Asia-Pacific Pefloxacin Mesylate Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Pefloxacin Mesylate Sales YoY (2017-2028) & (K Units)
    Figure 24. Latin America Pefloxacin Mesylate Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Pefloxacin Mesylate Sales YoY (2017-2028) & (K Units)
    Figure 26. Middle East & Africa Pefloxacin Mesylate Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Pefloxacin Mesylate Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Pefloxacin Mesylate in the World: Market Share by Pefloxacin Mesylate Revenue in 2021
    Figure 29. Global Pefloxacin Mesylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Pefloxacin Mesylate Sales Market Share by Type (2017-2028)
    Figure 31. Global Pefloxacin Mesylate Revenue Market Share by Type (2017-2028)
    Figure 32. Global Pefloxacin Mesylate Sales Market Share by Application (2017-2028)
    Figure 33. Global Pefloxacin Mesylate Revenue Market Share by Application (2017-2028)
    Figure 34. North America Pefloxacin Mesylate Sales Market Share by Type (2017-2028)
    Figure 35. North America Pefloxacin Mesylate Revenue Market Share by Type (2017-2028)
    Figure 36. North America Pefloxacin Mesylate Sales Market Share by Application (2017-2028)
    Figure 37. North America Pefloxacin Mesylate Revenue Market Share by Application (2017-2028)
    Figure 38. North America Pefloxacin Mesylate Sales Share by Country (2017-2028)
    Figure 39. North America Pefloxacin Mesylate Revenue Share by Country (2017-2028)
    Figure 40. United States Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Pefloxacin Mesylate Sales Market Share by Type (2017-2028)
    Figure 43. Europe Pefloxacin Mesylate Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Pefloxacin Mesylate Sales Market Share by Application (2017-2028)
    Figure 45. Europe Pefloxacin Mesylate Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Pefloxacin Mesylate Sales Share by Country (2017-2028)
    Figure 47. Europe Pefloxacin Mesylate Revenue Share by Country (2017-2028)
    Figure 48. Germany Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 49. France Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Pefloxacin Mesylate Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Pefloxacin Mesylate Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Pefloxacin Mesylate Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Pefloxacin Mesylate Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Pefloxacin Mesylate Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Pefloxacin Mesylate Revenue Share by Region (2017-2028)
    Figure 59. China Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 62. India Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 64. China Taiwan Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Pefloxacin Mesylate Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Pefloxacin Mesylate Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Pefloxacin Mesylate Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Pefloxacin Mesylate Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Pefloxacin Mesylate Sales Share by Country (2017-2028)
    Figure 73. Latin America Pefloxacin Mesylate Revenue Share by Country (2017-2028)
    Figure 74. Mexico Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 77. Colombia Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Pefloxacin Mesylate Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Pefloxacin Mesylate Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Pefloxacin Mesylate Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Pefloxacin Mesylate Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Pefloxacin Mesylate Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Pefloxacin Mesylate Revenue Share by Country (2017-2028)
    Figure 84. Turkey Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 86. UAE Pefloxacin Mesylate Revenue (2017-2028) & (US$ Million)
    Figure 87. Pefloxacin Mesylate Value Chain
    Figure 88. Pefloxacin Mesylate Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed